 |
185 Diseases |  |
81 Trials |
|
81 Trials |  |
6476 News |  |
| «12...70717273747576777879808182» |
- levetiracetam / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Seizure Prophylaxis in Aneurysm Repair (clinicaltrials.gov) - Feb 29, 2016
P4, N=17, Terminated, Sponsor: Indiana University
N=266 --> 17 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Feb 2016; Lack of enrollment - since the start of the study in 2013, only 17 subjects have consented. Of those, only 8 completed the study.
- cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Trial primary completion date: Busulfan and Cyclophosphamide Followed By ALLO BMT (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=30, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
Of those, only 8 completed the study. Trial primary completion date: Sep 2022 --> Sep 2025
- fludarabine IV / Generic mfg., busulfan / Generic mfg., levetiracetam / Generic mfg.
Trial primary completion date: Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=30, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
Trial primary completion date: Sep 2022 --> Sep 2025 Trial primary completion date: Dec 2015 --> Jun 2016
- || levetiracetam / Generic mfg.
Trial primary completion date: LIBERTY: LevetIracetam in Patients Being Treated for Epilepsy (clinicaltrials.gov) - Jan 21, 2016
P=N/A, N=450, Recruiting, Sponsor: Elpen Pharmaceutical Co. Inc.
Trial primary completion date: Dec 2015 --> Jun 2016 Trial primary completion date: Sep 2015 --> Sep 2016
- | levetiracetam / Generic mfg., oxcarbazepine / Generic mfg.
Enrollment closed, Enrollment change: Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE) (clinicaltrials.gov) - Jan 11, 2016
P3, N=78, Active, not recruiting, Sponsor: Emory University
Trial primary completion date: Sep 2015 --> Sep 2016 Recruiting --> Active, not recruiting | N=300 --> 78
- levetiracetam low dose (AGB101) / AgeneBio
New trial: Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia (clinicaltrials.gov) - Jan 6, 2016
P=N/A, N=30, Recruiting, Sponsor: University of Colorado, Denver
- || levetiracetam / Generic mfg.
Trial primary completion date: UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra (clinicaltrials.gov) - Dec 23, 2015
P4, N=516, Active, not recruiting, Sponsor: UCB Pharma
Recruiting --> Active, not recruiting | N=300 --> 78 Trial primary completion date: Aug 2016 --> Mar 2016
- brivaracetam / Generic mfg.
Enrollment open: A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers (clinicaltrials.gov) - Dec 10, 2015
P1, N=12, Recruiting, Sponsor: UCB Biopharma S.P.R.L.
Trial primary completion date: Aug 2016 --> Mar 2016 Not yet recruiting --> Recruiting
- levetiracetam / Generic mfg.
Trial primary completion date: LEV-AD: Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (clinicaltrials.gov) - Dec 4, 2015
P2, N=36, Recruiting, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2016 --> Dec 2016
- levetiracetam / Generic mfg.
Trial primary completion date: Seizure Activity in Alzheimer's Disease (clinicaltrials.gov) - Nov 16, 2015
P=N/A, N=20, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
Trial primary completion date: Jun 2016 --> Dec 2016 Trial primary completion date: Jul 2013 --> Dec 2015
- | levetiracetam / Generic mfg.
New P1/2 trial: Levetiracetam Treatment of Neonatal Seizures (clinicaltrials.gov) - Nov 14, 2015
P1/2, N=100, Not yet recruiting, Sponsor: The People's Hospital of Dehong Autonomous Prefecture
- | brivaracetam / Generic mfg.
New P1 trial: A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers (clinicaltrials.gov) - Nov 14, 2015
P1, N=12, Not yet recruiting, Sponsor: UCB Biopharma S.P.R.L.
- levetiracetam / Generic mfg.
New trial: Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE) (clinicaltrials.gov) - Nov 14, 2015
P=N/A, N=1, Not yet recruiting, Sponsor: Beijing Pins Medical Co., Ltd
- | levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
Enrollment open, HEOR: ESETT: Established Status Epilepticus Treatment Trial (clinicaltrials.gov) - Nov 5, 2015
P3, N=795, Recruiting, Sponsor: University of Virginia
Trial primary completion date: Jul 2013 --> Dec 2015 Not yet recruiting --> Recruiting
- levetiracetam / Generic mfg.
Trial primary completion date: NEOLEV2: Efficacy of Intravenous Levetiracetam in Neonatal Seizures (clinicaltrials.gov) - Oct 22, 2015
P1/2, N=100, Recruiting, Sponsor: Richard H. Haas
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2016 --> Dec 2016
- levetiracetam / Generic mfg.
Phase classification, Trial primary completion date: SPAR: Seizure Prophylaxis in Aneurysm Repair (clinicaltrials.gov) - Oct 22, 2015
P4, N=400, Recruiting, Sponsor: University of Michigan
Trial primary completion date: Sep 2016 --> Dec 2016 Phase classification: P1 --> P4 | Trial primary completion date: Feb 2015 --> Feb 2018
- ||||||| levetiracetam / Generic mfg., carbamazepine / Generic mfg.
Trial completion, Monotherapy: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures (clinicaltrials.gov) - Oct 9, 2015
P3, N=436, Completed, Sponsor: UCB Pharma SA
Phase classification: P1 --> P4 | Trial primary completion date: Feb 2015 --> Feb 2018 Active, not recruiting --> Completed
- | levetiracetam / Generic mfg.
New P4 trial: Levetiracetam Treatment of Neonatal Seizures (clinicaltrials.gov) - Sep 16, 2015
P4, N=100, Not yet recruiting, Sponsor: Children's Hospital of Fudan University
- levetiracetam / Generic mfg.
Enrollment open, Enrollment change, Trial primary completion date: 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients (clinicaltrials.gov) - Aug 21, 2015
P4, N=82, Recruiting, Sponsor: University of Florida
Active, not recruiting --> Completed Not yet recruiting --> Recruiting | N=234 --> 82 | Trial primary completion date: Sep 2020 --> Sep 2017
- ||| levetiracetam / Generic mfg.
Enrollment open: LIBERTY: LevetIracetam in Patients Being Treated for Epilepsy (clinicaltrials.gov) - Aug 18, 2015
P=N/A, N=450, Recruiting, Sponsor: Elpen Pharmaceutical Co. Inc.
Not yet recruiting --> Recruiting | N=234 --> 82 | Trial primary completion date: Sep 2020 --> Sep 2017 Not yet recruiting --> Recruiting
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Trial primary completion date: Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders (clinicaltrials.gov) - Aug 14, 2015
P2, N=50, Recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting --> Recruiting Trial primary completion date: May 2016 --> May 2017
- levetiracetam / Generic mfg.
Trial initiation date, Trial primary completion date: 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients (clinicaltrials.gov) - Jul 20, 2015
P4, N=234, Not yet recruiting, Sponsor: University of Florida
Trial primary completion date: May 2016 --> May 2017 Initiation date: Feb 2015 --> Aug 2015 | Trial primary completion date: Mar 2020 --> Sep 2020
- levetiracetam / Generic mfg.
Trial completion, Trial initiation date: Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia (clinicaltrials.gov) - Jun 23, 2015
P4, N=24, Completed, Sponsor: Drexel University College of Medicine
Initiation date: Feb 2015 --> Aug 2015 | Trial primary completion date: Mar 2020 --> Sep 2020 Recruiting --> Completed | Initiation date: Jan 2008 --> Nov 2006
- levetiracetam / Generic mfg.
Trial completion: A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM (clinicaltrials.gov) - Jun 22, 2015
P2, N=44, Completed, Sponsor: University of Rochester
Recruiting --> Completed | Initiation date: Jan 2008 --> Nov 2006 Recruiting --> Completed
- levetiracetam / Generic mfg., oxcarbazepine / Generic mfg.
Trial primary completion date: Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE) (clinicaltrials.gov) - Jun 11, 2015
P3, N=300, Recruiting, Sponsor: Emory University
Recruiting --> Completed Trial primary completion date: Jul 2015 --> Apr 2016
- levetiracetam / Generic mfg., topiramate / Generic mfg.
Trial completion: Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures (clinicaltrials.gov) - Jun 1, 2015
P4, N=343, Completed, Sponsor: UCB Korea Co. Ltd.
Trial primary completion date: Jul 2015 --> Apr 2016 Active, not recruiting --> Completed
- ||||||| levetiracetam / Generic mfg.
Trial completion, Monotherapy: An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy (clinicaltrials.gov) - May 21, 2015
P3, N=71, Completed, Sponsor: UCB Japan Co. Ltd.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change, Post-transplantation: T-Cell Depleted Double UCB for Refractory AML (clinicaltrials.gov) - May 16, 2015
P2, N=3, Terminated, Sponsor: Masonic Cancer Center, University of Minnesota
Active, not recruiting --> Completed N=24 --> 3
- ||||| levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
Trial initiation date, HEOR: ESETT: Established Status Epilepticus Treatment Trial (clinicaltrials.gov) - May 8, 2015
P3, N=795, Not yet recruiting, Sponsor: University of Virginia
N=24 --> 3 Initiation date: Jul 2014 --> Aug 2015
- levetiracetam / Generic mfg.
Enrollment change: A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM (clinicaltrials.gov) - Apr 30, 2015
P2, N=43, Recruiting, Sponsor: University of Rochester
Initiation date: Jul 2014 --> Aug 2015 N=60 --> 43
- levetiracetam / Generic mfg.
Trial primary completion date: Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients. (clinicaltrials.gov) - Apr 14, 2015
P1, N=50, Active, not recruiting, Sponsor: Kessler Foundation
N=60 --> 43 Trial primary completion date: Jun 2014 --> Jun 2016
- levetiracetam / Generic mfg.
Trial primary completion date: Seizure Prophylaxis in Aneurysm Repair (clinicaltrials.gov) - Apr 14, 2015
P4, N=266, Recruiting, Sponsor: Indiana University
Trial primary completion date: Jun 2014 --> Jun 2016 Trial primary completion date: Dec 2015 --> Dec 2017
- zonisamide / Generic mfg., levetiracetam / Generic mfg., topiramate / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism (clinicaltrials.gov) - Apr 7, 2015
P2, N=85, Terminated, Sponsor: Boston Medical Center
Trial primary completion date: Dec 2015 --> Dec 2017 N=160 --> 85 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Aug 2013; Recruitment goals could not be met before ending of funding for this project.
- ||||| levetiracetam / Generic mfg., carbamazepine / Generic mfg.
Enrollment closed, Monotherapy: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures (clinicaltrials.gov) - Mar 31, 2015
P3, N=436, Active, not recruiting, Sponsor: UCB Pharma SA
N=160 --> 85 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Aug 2013; Recruitment goals could not be met before ending of funding for this project. Recruiting --> Active, not recruiting
- ||||| levetiracetam / Generic mfg.
Enrollment change: Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy (clinicaltrials.gov) - Mar 25, 2015
P3, N=217, Completed, Sponsor: UCB Pharma SA
Recruiting --> Active, not recruiting N=300 --> 217
- levetiracetam / Generic mfg.
Enrollment change: Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus (clinicaltrials.gov) - Mar 10, 2015
P2, N=0, Withdrawn, Sponsor: University Hospital, Basel, Switzerland
N=300 --> 217 N=20 --> 0
- levetiracetam / Generic mfg.
Trial primary completion date: Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method (clinicaltrials.gov) - Mar 5, 2015
P3, N=97, Completed, Sponsor: UCB Pharma
N=20 --> 0 Trial primary completion date: Nov 2007 --> Jan 2007
- |||||||||| New P3 trial, Adverse events: Pharmacovigilance in Gerontopsychiatric Patients (clinicaltrials.gov) - Mar 2, 2015
P3, N=2000, Recruiting, Sponsor: Hannover Medical School
- |||| levetiracetam / Generic mfg.
Trial completion: A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures (clinicaltrials.gov) - Feb 28, 2015
P2, N=87, Completed, Sponsor: UCB Pharma
Trial primary completion date: Nov 2007 --> Jan 2007 No longer recruiting --> Completed
- ||| levetiracetam / Generic mfg.
Clinical: LIBERTY: LevetIracetam in Patients Being Treated for Epilepsy (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=450, Not yet recruiting, Sponsor: Elpen Pharmaceutical Co. Inc.
- | Yescarta (axicabtagene ciloleucel) / Gilead
New P1/2 trial: ZUMA-1: Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma (clinicaltrials.gov) - Jan 28, 2015
P1/2, N=124, Recruiting, Sponsor: Kite Pharma, Inc.
- | levetiracetam / Generic mfg.
New P4 trial: 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients (clinicaltrials.gov) - Jan 8, 2015
P4, N=234, Not yet recruiting, Sponsor: University of Florida
- phenytoin / Generic mfg., levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
Clinical: Antiepileptic Drugs and Vascular Risk Markers (clinicaltrials.gov) - Nov 25, 2014
P=N/A, N=52, Terminated, Sponsor: Thomas Jefferson University
No longer recruiting --> Completed N=40 --> 52
- || levetiracetam / Generic mfg., topiramate / Generic mfg.
Phase classification, Monotherapy: A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy (clinicaltrials.gov) - Nov 18, 2014
P3, N=282, Recruiting, Sponsor: Janssen Research & Development, LLC
N=40 --> 52 Phase classification: P4 --> P3
- |||| levetiracetam / Generic mfg., topiramate / Generic mfg.
Enrollment open, Monotherapy: A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy (clinicaltrials.gov) - Sep 29, 2014
P4, N=282, Recruiting, Sponsor: Janssen Research & Development, LLC
Phase classification: P4 --> P3 Not yet recruiting --> Recruiting
- levetiracetam / Generic mfg.
Trial primary completion date: Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia (clinicaltrials.gov) - Sep 19, 2014
P2, N=7, Recruiting, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2014 --> Sep 2016
- levetiracetam / Generic mfg.
New P2 trial: LEVNEONAT-1: Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study (clinicaltrials.gov) - Aug 29, 2014
P2, N=50, Not yet recruiting, Sponsor: University Hospital, Tours
- | levetiracetam / Generic mfg., carbamazepine / Generic mfg.
New P4 trial, Monotherapy: The Effects on Cognitive Function of Levetiracetam (Keppra (clinicaltrials.gov) - Aug 5, 2014
P4, N=75, Completed, Sponsor: Yonsei University
- | Nitredon (nitrazepam) / Remedica, Diacomit (stiripentol) / Biocodex, Meiji Seika
New P4 trial: Ketogenic Diet in Infants With Epilepsy (KIWE) (clinicaltrials.gov) - Aug 1, 2014
P4, N=160, Not yet recruiting, Sponsor: University College, London
- levetiracetam / Generic mfg., oxcarbazepine / Generic mfg.
Trial completion, Monotherapy: Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (clinicaltrials.gov) - Aug 1, 2014
P4, N=353, Completed, Sponsor: UCB Korea Co. Ltd.
Trial primary completion date: Sep 2014 --> Sep 2016 Active, not recruiting --> Completed